
The exosomes, shown as small red punctate clusters, are taken up by neurons, shown as green cell extensions surrounding a blue nucleus.
Human clinical trials could begin as early as next year
A team of researchers at the University of Georgia’s Regenerative Bioscience Center and ArunA Biomedical, a UGA startup company, have developed a new treatment for stroke that reduces brain damage and accelerates the brain’s natural healing tendencies in animal models. They published their findings in the journal Translational Stroke Research.
The research team led by UGA professor Steven Stice and Nasrul Hoda of Augusta University created a treatment called AB126 using extracellular vesicles (EV), fluid-filled structures known as exosomes, which are generated from human neural stem cells.
Fully able to cloak itself within the bloodstream, this type of regenerative EV therapy appears to be the most promising in overcoming the limitations of many cell therapies—with the ability for exosomes to carry and deliver multiple doses—as well as the ability to store and administer treatment. Small in size, the tiny tubular shape of an exosome allows EV therapy to cross barriers that cells cannot.
“This is truly exciting evidence, because exosomes provide a stealth-like characteristic, invisible even to the body’s own defenses,” said Stice, Georgia Research Alliance Eminent Scholar and D.W. Brooks Distinguished Professor in the College of Agricultural and Environmental Sciences. “When packaged with therapeutics, these treatments can actually change cell progression and improve functional recovery.”
Following the administration of AB126, the researchers used MRI scans to measure brain atrophy rates in preclinical, age-matched stroke models, which showed an approximately 35 percent decrease in the size of injury and 50 percent reduction in brain tissue loss—something not observed acutely in previous studies of exosome treatment for stroke.
Outside of rodents, the results were replicated by Franklin West, associate professor of animal and dairy science, and fellow RBC members using a porcine model of stroke—the only one of its kind in the U.S.
Based on these pre-clinical results, ArunA Biomedical plans to begin human studies in 2019, said Stice, who is also chief scientific officer of ArunA Biomedical.
“Until now, we had very little evidence specific to neural exosome treatment and the ability to improve motor function,” said Stice. “Just days after stroke, we saw better mobility, improved balance and measurable behavioral benefits in treated animal models.”
Named as part of the ‘stroke belt’ region, Georgia continues to exceed the national average in stroke deaths, which is the third leading cause of death in the U.S., with more than 140,000 Americans dying each year, according to the Centers for Disease Control and Prevention.
ArunA recently unveiled advances to the company’s proprietary neural cell platform for the production of exosome manufacturing. Today, ArunA’s manufacturing process positions the company to produce AB126 exosomes at a scale to meet early clinical demand. The company has plans to expand this initiative beyond stroke for preclinical studies in epilepsy, traumatic brain and spinal cord injuries later this year.
Learn more: Stem-cell based stroke treatment repairs brain tissue
The Latest on: Stroke treatment
[google_news title=”” keyword=”Stroke treatment” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Stroke treatment
- What Experts Say About Cracking Your Neck And Your Risk Of Strokeon February 3, 2023 at 3:04 pm
A recent viral tweet suggested that a woman developed stroke symptoms after a neck adjustment at the chiropractor. Here’s what experts say.View Entire Post › ...
- This smartphone app detects if users are having a strokeon February 3, 2023 at 9:30 am
FAST.AI uses artificial intelligence to check for facial asymmetry and arm weakness, two common warning signs.
- Drug made from celery seeds may boost chances of recovering from a strokeon February 3, 2023 at 7:00 am
"If the results are confirmed in other trials, this may lead to more options to treat strokes caused by clots." The post Drug made from celery seeds may boost chances of recovering from a stroke ...
- New app may help identify stroke symptoms as they happenon February 3, 2023 at 4:57 am
An analysis found that the app accurately detected stroke-associated facial asymmetry in nearly 100% of patients. The post New app may help identify stroke symptoms as they happen appeared first on ...
- Black, Hispanic patients less likely to be treated for complications of strokeon February 3, 2023 at 1:00 am
Having a stroke is a life-altering experience, and complications can crop up afterward, but a new study finds the color of your skin may determine whether you are treated for them.
- Stroke Treatment Drugs Market 2023: Magnificent Analysis Report for Huge Growth with Forthcoming Challenges Forecast to 2027on February 2, 2023 at 8:04 pm
Feb 03, 2023 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." “Stroke Treatment Drugs Market” ...
- Trial shows the benefit of using a celery seed-derived medication after clot treatment in stroke patientson February 2, 2023 at 2:59 pm
People who had an ischemic (clot-caused) stroke and were treated with a clot-busting medication and/or mechanical clot removal and also received butylphthalide, a medication initially compounded from ...
- Black Stroke Survivors Less Likely to Get Treated for Complicationson February 2, 2023 at 2:00 pm
Having a stroke is a life-altering experience, and complications can crop up afterwards, but a new study finds the color of your skin ...
- Black and Hispanic people in US less likely to get treatment for stroke complicationson February 2, 2023 at 2:00 am
Analysis of 20 years of electronic health records across the U.S. finds Black and Hispanic stroke survivors were less likely than white stroke survivors to receive treatment for common complications ...
- Novel celery seed-derived medicine given after clot treatment may improve stroke outcomeson February 2, 2023 at 2:00 am
People who had an ischemic (clot-caused) stroke and were treated with a clot-busting medication and/or mechanical clot removal and also received butylphthalide, a medication initially compounded from ...
via Bing News